<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Radiation Research</title>
<title_fa>نشریه پرتو پژوه</title_fa>
<short_title>Int J Radiat Res</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ijrr.com</web_url>
<journal_hbi_system_id>79</journal_hbi_system_id>
<journal_hbi_system_user>journal79</journal_hbi_system_user>
<journal_id_issn>2322-3243</journal_id_issn>
<journal_id_issn_online>2345-4229</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/ijrr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>17</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Safe chemotherapy and targeted therapy for 
treating locally advanced NPC in a G6PD-deficient patient: case report and literature review
</title>
	<subject_fa>Radiation Biology</subject_fa>
	<subject>Radiation Biology</subject>
	<content_type_fa>مطالعه موردي</content_type_fa>
	<content_type>Case Report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;The article was first report a case of a 32-year-old female with NPC that is G6PD-deficient. The patient completed induction chemotherapy and concomitant chemoradiotherapy successfully. The patient experienced grade 1 neutropenia , grade 1 diarrhea, and grade 2 acne-like skin reactions during the three cycles of&amp;nbsp; induction chemotherapy. Grade 1 neutropenia, grade 1 diarrhea, grade 2 oral mucositis&amp;nbsp; and grade 1&amp;nbsp; skin reactions were observed during the concomitant chemoradiotherapy. No hemolytic events were observed. We conclude that it is safe for G6PD-deficient patients with NPC to received chemotherapy&amp;nbsp;and&amp;nbsp;targeted&amp;nbsp;therapy.&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>nasopharyngeal carcinoma, G6PD deficiency, chemotherapy, cetuximab, radiotherapy.</keyword>
	<start_page>505</start_page>
	<end_page>508</end_page>
	<web_url>http://ijrr.com/browse.php?a_code=A-10-1-810&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Y.M </first_name>
	<middle_name></middle_name>
	<last_name>Jiang </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>7900319475328460014326</code>
	<orcid>7900319475328460014326</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Cancer Hospital of Guangxi Medical University, Nanning530021, People's Republic of China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>X.D. </first_name>
	<middle_name></middle_name>
	<last_name>Zhu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zhuxiaodonggxmu@163.com</email>
	<code>7900319475328460014327</code>
	<orcid>7900319475328460014327</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Radiation Oncology, Cancer Hospital of Guangxi Medical University, Nanning530021, People's Republic of China</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
